US based company GenEdit has announced the completion of a $8.5 million Series Seed financing round led by new...
Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...
Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...
Merck, a leading science and technology company has entered into a licensing agreement with Cyclica Inc. for the use of ...
Seattle-based biotechnology company, Impel NeuroPharma has announced that it has completed a Series D financing totaling...
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...
Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...
Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...
Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...
Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
Editas Medicine, a genome editing company has announced results from experiments to demonstrate expanded CRISPR genome e...
Auris Health, Inc. has announced the close of a $220 million equity financing led by Partner Fund Management. New invest...
Biocartis Group NV, an innovative molecular diagnostics company, has entered into an agreement with AstraZeneca, a globa...
The U.S. Food and Drug Administration has approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton m...
Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory dise...
GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SB...
Pharma company, Incyte has announced the appointment of Dashyant Dhanak as Executive Vice President and Chief Scientific...
